title: Enalapril: a long-acting angiotensin-converting enzyme inhibitor.
abstract: The development of angiotensin-converting enzyme (ACE) inhibitors is of landmark importance in the understanding and treatment of cardiovascular disorders, particularly hypertension and congestive heart failure. Enalapril has recently joined captopril as an approved, orally active ACE inhibitor. Like captopril, it has been effective in the treatment of hypertension and congestive heart failure, with minimal adverse reactions noted. Differences in pharmacology exist between enalapril and captopril which may prove to be of clinical significance.
authors.affiliation: Department of Medicine, Long Island College Hospital, Brooklyn, New York.
authors.forename: M
authors.initials: M
authors.lastname: Borek
authors.forename: S
authors.initials: S
authors.lastname: Charlap
authors.forename: W
authors.initials: W
authors.lastname: Frishman
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D004656:Enalapril / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril